Delphinus Medical Technologies
Curated by SignalPlatform for breast ultrasound imaging
Overview
Delphinus Medical Technologies has designed and developed SoftVue, a three-dimensional and tomographic ultrasound imaging and risk assessment device that examines women’s breasts for the presence of benign and/or malignant masses, assesses breast cancer risks, diagnoses breast diseases, and monitors therapy. Sound and water are the basis of its technology, where acoustic signals resonating within breast tissue yield a unique signature that it measures. SoftVue has received FDA clearance for diagnostic imaging purposes and is not intended for use as a replacement for screening mammography.
Key facts
- Founded
- 2010
- Headquarters
- Plymouth, United States
- Stage
- Sign up to view
- Industry
- Health Technology
Business model
- 1 product or service
- Sign up to view
Contact
- Primary office
- Sign up to view
- Phone
- Sign up to view